Announcements

GCR accords an initial rating of A+(ZA) to Sizwe Medical Fund; Outlook Stable

Johannesburg, 31 July 2015–Global Credit Ratings has today assigned a national scale claims paying ability rating to Sizwe Medical Fund of A+(ZA); with the outlook accorded as Stable.

SUMMARY RATING RATIONALE

Global Credit Ratings (“GCR”) has accorded the above credit rating to Sizwe Medical Fund (“Sizwe”) based on the following key criteria:

Sizwe has exhibited a materially elevated level of earnings capacity over the past two years, representing a material rating strength. In this regard, the scheme registered an average net healthcare margin of 6.8% between FY13 and FY14, and has budgeted for a further strong margin of 4.5% in FY15. Coupled with consistent investment yields, this has resulted in R459m in cumulative net surpluses being generated over the corresponding period, with a R175m net surplus budgeted for FY15. The distinct turnaround in healthcare performance has been achieved through the deployment of targeted corrective pricing, reducing the claims ratio to a low 79.9% in FY14, with repriced contribution levels serving as a foundation for future earnings.

Sizwe’s solvency is viewed to be very strong, and a key rating strength. Robust reserve accumulation over the past 2 years has seen the members’ surplus increase by a compound annual growth rate of 32%, amounting to R991m at FYE14 (versus R566m at FYE12). Accordingly, in conjunction with reducing membership volumes, this resulted in the statutory solvency margin rising to a very strong 46% in FY14. Continued reserve accumulation is expected to see solvency strength persist over the rating horizon (FY15 forecast: 49%), with management aiming to maintain the solvency margin above 40% over the medium term.

Sizwe’s liquidity has consistently improved over the review period, with net cash coverage strengthening to a moderately strong 2.7 months in FY14. The upward liquidity trend has been underpinned by healthy operational cash flow generation, which is expected to be sustained at moderate levels over the rating outlook period. The balance of Sizwe’s investment portfolio currently exhibits a fairly contained level of risk, with the value of listed equities and bonds corresponding to 32% of the total investment portfolio at FYE14 (and 35% of the members’ surplus). Going forward, management is likely to adopt a revised asset allocation strategy, which may cause the weighting of listed equities and bonds to rise.

Sizwe’s membership base scale is viewed to be intermediate, with short term growth initiatives taken into consideration. In this regard, while total beneficiaries remain fairly high (FY14: 120,005), consistent membership losses over the review period cumulatively amount to 43,223 (a net loss of 26% relative to FY10). The scheme expects this trend to reverse from FY15 onward, with increased penetration into existing employer groups expected to be supported by marketing and brand management strategies.

The lifting of Sizwe’s curatorship and the accompanying set of corrective measures that have been implemented to address highlighted items, is positively considered, given the strengthening of the governance structure and strengthened operational controls and processes of the fund going forward.

The rating could benefit positively over the medium term from the attainment of material increases in membership scale, facilitating an improved diversification level and member age profile. This must be coupled with the generation of consistent net surpluses, accompanied by the maintenance of credit protection measures at sound levels. A significant deterioration in financial performance, including a considerable weakening of key liquidity metrics and solvency measures, as well as considerable membership losses below comfortable levels, may give rise to negative rating pressure.

NATIONAL SCALE RATINGS HISTORY
Initial rating/Last rating (July 2015)
Claims paying ability: A+(ZA)
Outlook: Stable

ANALYTICAL CONTACTS

Primary Analyst   Secondary Analyst
Marc Chadwick   Catherine Zimba
Sector Head: Insurance Ratings   Junior Analyst
(011) 784-1771   (011) 784-1771
chadwick@globalratings.net   catherinez@globalratings.net
     
Committee Chairperson    
Sheri Few    
Senior Analyst    
(011) 784-1771    
few@globalratings.net    

APPLICABLE METHODOLOGIES AND RELATED RESEARCH

Criteria for Rating South African Medical Schemes, updated April 2015.

RATING LIMITATIONS AND DISCLAIMERS

ALL GCR’S CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTP://GLOBALRATINGS.NET/UNDERSTANDING-RATINGS. IN ADDITION, GCR’S RATING SCALES AND DEFINITIONS ARE ALSO AVAILABLE FOR DOWNLOAD AT THE FOLLOWING LINK: HTTP://GLOBALRATINGS.NET/RATINGS-INFO. GCR’S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, PUBLICATION TERMS AND CONDITIONS AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE AT HTTP://GLOBALRATINGS.NET.

GLOSSARY OF TERMS/ACRONYMS USED IN THIS DOCUMENT AS PER GCR’S INSURANCE GLOSSARY

Accumulated funds An amount representing the accumulation of historical and current net surpluses and deficits, held for the benefit of members and their dependants
Assets A resource with economic value that a company owns or controls with the expectation that it will provide future benefit.
Balance Sheet Also known as a Statement of Financial Position. A statement of a company’s assets and liabilities provided for the benefit of shareholders and regulators. It gives a snapshot at a specific point in time of the assets the company holds and how they have been financed.
Benefits Financial reimbursement and other services provided covered by medical schemes under the terms of a medical scheme plan.
Bond A long term debt instrument issued by either: a company, institution or the government to raise funds.
Claim A request for payment of a loss, which may come under the terms of a medical scheme plan.
Commission A certain percentage of premiums produced that is received or paid out as compensation by a medical scheme to agents and brokers.
Coverage The scope of the protection provided under a contract of a medical scheme plan.
Interest Money paid for the use of money.
Liquidity The ability of a medical scheme to convert its assets into cash to pay claims if necessary.
Loss The happening of the event for which a medical scheme pays.
Market Value The price for which something would sell, especially the value of certain types of assets, such as stocks and bonds. It is based on what they would sell for under current market conditions.
Members’ surplus Accumulated funds plus revaluation reserves.
Portfolio The total securities owned by a medical scheme.
Provision A technical reserve of a medical scheme established to provide for the future liability for claims which have occurred but which have not yet been settled.
Risk (1) Uncertainty as to the outcome of an event when two or more possibilities exist. (2) A person or thing covered by a medical scheme.
Securities Evidences of a debt or of ownership, as stocks, bonds, and checks.
Solvency Reserves (accumulated funds or members’ surplus) expressed as a percentage of contributions (gross or net).
Statutory Required by or having to do with law or statute.
Term The period of time for which a policy or bond is issued.
Valuation Estimation of the value of an item, usually by appraisal.

For a more detailed glossary of terms, please click here


SALIENT FEATURES OF ACCORDED RATINGS

GCR affirms that a.) no part of the rating was influenced by any other business activities of the credit rating agency; b.) the rating was based solely on the merits of the rated entity, security or financial instrument being rated; c.) such rating was an independent evaluation of the risks and merits of the rated entity, security or financial instrument; and d.) the validity of the rating is for a maximum of 12 months, or earlier as indicated by the applicable credit rating document.

Sizwe Medical Fund participated in the rating process via face-to-face management meetings, teleconferences and other written correspondence. Furthermore, the quality of information received was considered adequate and has been independently verified where possible.

The credit rating has been disclosed to Sizwe Medical Fund with no contestation of the rating.

The information received from Sizwe Medical Fund and other reliable third parties to accord the credit rating included:

  • The 2014 audited annual financial statements
  • Four years of comparative audited numbers
  • Unaudited interim results to 30 April 2015
  • Budgeted financial statements for 2015
  • Other related documents.

The rating above was solicited by, or on behalf of, the rated client, and therefore, GCR has been compensated for the provision of the rating.

image_pdfPDF View

Leave a Reply



ALL GCR CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS, TERMS OF USE OF SUCH RATINGS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS, TERMS OF USE AND DISCLAIMERS BY FOLLOWING THIS LINK:HTTP://GCRRATINGS.COM. IN ADDITION, RATING SCALES AND DEFINITIONS ARE AVAILABLE ON GCR’S PUBLIC WEB SITE AT WWW.GCRRATINGS.COM/RATING_INFORMATION. PUBLISHED RATINGS, CRITERIA, AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. GCR's CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, COMPLIANCE, AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THIS SITE.

CREDIT RATINGS ISSUED AND RESEARCH PUBLICATIONS PUBLISHED BY GCR, ARE GCR’S OPINIONS, AS AT THE DATE OF ISSUE OR PUBLICATION THEREOF, OF THE RELATIVE FUTURE CREDIT RISK OF ENTITIES, CREDIT COMMITMENTS, OR DEBT OR DEBT-LIKE SECURITIES. GCR DEFINES CREDIT RISK AS THE RISK THAT AN ENTITY MAY NOT MEET ITS CONTRACTUAL AND/OR FINANCIAL OBLIGATIONS AS THEY BECOME DUE. CREDIT RATINGS DO NOT ADDRESS ANY OTHER RISK, INCLUDING BUT NOT LIMITED TO: FRAUD, MARKET LIQUIDITY RISK, MARKET VALUE RISK, OR PRICE VOLATILITY. CREDIT RATINGS AND GCR’S OPINIONS INCLUDED IN GCR’S PUBLICATIONS ARE NOT STATEMENTS OF CURRENT OR HISTORICAL FACT. CREDIT RATINGS AND GCR’S PUBLICATIONS DO NOT CONSTITUTE OR PROVIDE INVESTMENT OR FINANCIAL ADVICE, AND CREDIT RATINGS AND GCR’S PUBLICATIONS ARE NOT AND DO NOT PROVIDE RECOMMENDATIONS TO PURCHASE, SELL OR HOLD PARTICULAR SECURITIES. NEITHER GCR’S CREDIT RATINGS, NOR ITS PUBLICATIONS, COMMENT ON THE SUITABILITY OF AN INVESTMENT FOR ANY PARTICULAR INVESTOR. GCR ISSUES ITS CREDIT RATINGS AND PUBLISHES GCR’S PUBLICATIONS WITH THE EXPECTATION AND UNDERSTANDING THAT EACH INVESTOR WILL MAKE ITS OWN STUDY AND EVALUATION OF EACH SECURITY THAT IS UNDER CONSIDERATION FOR PURCHASE, HOLDING OR SALE.

Copyright © 2021 GCR INFORMATION PUBLISHED BY GCR MAY NOT BE COPIED OR OTHERWISE REPRODUCED OR DISCLOSED, IN WHOLE OR IN PART, IN ANY FORM OR MANNER OR BY ANY MEANS WHATSOEVER, BY ANY PERSON WITHOUT GCR’S PRIOR WRITTEN CONSENT. Credit ratings are solicited by, or on behalf of, the issuer of the instrument in respect of which the rating is issued, and GCR is compensated for the provision of these ratings. Information sources used to prepare the ratings are set out in each credit rating report and/or rating notification and include the following: parties involved in the ratings and public information. All information used to prepare the ratings is obtained by GCR from sources reasonably believed by it to be accurate and reliable. Although GCR will at all times use its best efforts and practices to ensure that the information it relies on is accurate at the time, GCR does not provide any warranty in respect of, nor is it otherwise responsible for, the accurateness of such information.GCR adopts all reasonable measures to ensure that the information it uses in assigning a credit rating is of sufficient quality and that such information is obtained from sources that GCR, acting reasonably, considers to be reliable, including, when appropriate, independent third-party sources. However, GCR cannot in every instance independently verify or validate information received in the rating process. Under no circumstances shall GCR have any liability to any person or entity for (a) any loss or damage suffered by such person or entity caused by, resulting from, or relating to, any error made by GCR, whether negligently (including gross negligence) or otherwise, or other circumstance or contingency outside the control of GCR or any of its directors, officers, employees or agents in connection with the procurement, collection, compilation, analysis, interpretation, communication, publication or delivery of any such information, or (b) any direct, indirect, special, consequential, compensatory or incidental damages whatsoever (including without limitation, lost profits) suffered by such person or entity, as a result of the use of or inability to use any such information. The ratings, financial reporting analysis, projections, and other observations, if any, constituting part of the information contained in each credit rating report and/or rating notification are, and must be construed solely as, statements of opinion and not statements of fact or recommendations to purchase, sell or hold any securities. Each user of the information contained in each credit rating report and/or rating notification must make its own study and evaluation of each security it may consider purchasing, holding or selling. NO WARRANTY, EXPRESS OR IMPLIED, AS TO THE ACCURACY, TIMELINESS, COMPLETENESS, MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE OF ANY SUCH RATING OR OTHER OPINION OR INFORMATION IS GIVEN OR MADE BY GCR IN ANY FORM OR MANNER WHATSOEVER.